Hodges Capital Management Inc. decreased its holdings in shares of Research Solutions Inc. (NASDAQ:RSSS - Free Report) by 51.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 250,000 shares of the company's stock after selling 264,595 shares during the period. Hodges Capital Management Inc. owned 0.77% of Research Solutions worth $650,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Northern Trust Corp raised its position in Research Solutions by 13.2% during the 4th quarter. Northern Trust Corp now owns 42,706 shares of the company's stock valued at $177,000 after purchasing an additional 4,989 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in Research Solutions during the 4th quarter valued at approximately $56,000. Millennium Management LLC bought a new position in Research Solutions during the 4th quarter valued at approximately $65,000. Occudo Quantitative Strategies LP bought a new position in Research Solutions during the 4th quarter valued at approximately $97,000. Finally, NewEdge Advisors LLC bought a new position in Research Solutions during the 1st quarter valued at approximately $71,000. Institutional investors own 33.60% of the company's stock.
Research Solutions Price Performance
RSSS opened at $3.29 on Friday. Research Solutions Inc. has a one year low of $2.32 and a one year high of $4.24. The business has a 50 day simple moving average of $2.90 and a two-hundred day simple moving average of $2.82. The firm has a market capitalization of $106.79 million, a price-to-earnings ratio of -23.50, a PEG ratio of 3.68 and a beta of 0.66.
Research Solutions Company Profile
(
Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.